Rituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial

Felicitas Hitz, Natalie Fischer, Th. Pabst, Clemens B. Caspar, Grégoire Berthod, Klaus Eckhardt, Simona Berardi Vilei, Emanuele Zucca, Ulrich Mey

Annals of Hematology · 2013 · 23 citations · 25 references

DOIFull text

Open access

Concepts

References

25